Assisted Reproductive Technologies Drugs - Global and China Top Players Market Share and Ranking 2023
Assisted reproductive technology (ART) is used to treat infertility. It includes fertility treatments that handle both eggs and sperm. A number of different agents are used to achieve controlled ovarian hyperstimulation. These include clomiphene, GnRH analogues, menotropins, urofollitropin, highly purified FSH, and recombinant human FSH (rh-FSH), etc.
This report studies and analyses global Assisted Reproductive Technologies Drugs status and future trends, to help determine the Assisted Reproductive Technologies Drugs market size of the total market opportunity by Type, by Channel, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Assisted Reproductive Technologies Drugs, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Assisted Reproductive Technologies Drugs market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Assisted Reproductive Technologies Drugs by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Assisted Reproductive Technologies Drugs by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Assisted Reproductive Technologies Drugs key consuming regions, consumption value and demand structure
(5) Assisted Reproductive Technologies Drugs industry chains, upstream, midstream and downstream
According to YH Research, the global market for Assisted Reproductive Technologies Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Assisted Reproductive Technologies Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Assisted Reproductive Technologies Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital Pharmacy grew percent to account for percent of the total market sales, and Specialty & Retail Pharmacy grew percent.
Market segment by players, this report covers
Merck
MSD
Ipsen
Ferring
Organon
Solvay
Besins
Zhejiang Xianju
Changchun GeneScience
Hybio Pharmaceutical
Livzon Pharmaceutical
Market segment by Type, covers
Down-Regulation Drugs
Ovulation Stimulation Drugs
Ovulation Inducing Drugs
Luteal Support Medications
Market segment by Channel, can be divided into
Hospital Pharmacy
Specialty & Retail Pharmacy
Online Pharmacy
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Assisted Reproductive Technologies Drugs product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Assisted Reproductive Technologies Drugs market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Assisted Reproductive Technologies Drugs market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Assisted Reproductive Technologies Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Channel, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Assisted Reproductive Technologies Drugs Definition
1.2 Global Assisted Reproductive Technologies Drugs Market Size and Forecast
1.3 China Assisted Reproductive Technologies Drugs Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Assisted Reproductive Technologies Drugs Market Size: China VS Global Growth Rate, 2018-2029
1.6 Assisted Reproductive Technologies Drugs Market Dynamics
1.6.1 Assisted Reproductive Technologies Drugs Market Drivers
1.6.2 Assisted Reproductive Technologies Drugs Market Restraints
1.6.3 Assisted Reproductive Technologies Drugs Industry Trends
1.6.4 Assisted Reproductive Technologies Drugs Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Assisted Reproductive Technologies Drugs, Global Market Share by Company, 2018-2023
2.2 Global Assisted Reproductive Technologies Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Assisted Reproductive Technologies Drugs Concentration Ratio
2.4 Global Assisted Reproductive Technologies Drugs Mergers & Acquisitions, Expansion Plans
2.5 Global Assisted Reproductive Technologies Drugs Major Companies Product Type
2.6 Head Office and Assisted Reproductive Technologies Drugs Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Assisted Reproductive Technologies Drugs, China Market Share by Company, 2018-2023
3.2 China Assisted Reproductive Technologies Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Assisted Reproductive Technologies Drugs Industry Chain
4.2 Assisted Reproductive Technologies Drugs Upstream Analysis
4.2.1 Assisted Reproductive Technologies Drugs Core Raw Materials
4.2.2 Main Manufacturers of Assisted Reproductive Technologies Drugs Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Assisted Reproductive Technologies Drugs Production Mode
4.6 Assisted Reproductive Technologies Drugs Procurement Model
4.7 Assisted Reproductive Technologies Drugs Industry Sales Model and Sales Channels
4.7.1 Assisted Reproductive Technologies Drugs Sales Model
4.7.2 Assisted Reproductive Technologies Drugs Typical Distributors
5 Sights by Type
5.1 Assisted Reproductive Technologies Drugs Classification
5.1.1 Down-Regulation Drugs
5.1.2 Ovulation Stimulation Drugs
5.1.3 Ovulation Inducing Drugs
5.1.4 Luteal Support Medications
5.2 By Type, Global Assisted Reproductive Technologies Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029
6 Sights by Channel
6.1 Assisted Reproductive Technologies Drugs Segment by Channel
6.1.1 Hospital Pharmacy
6.1.2 Specialty & Retail Pharmacy
6.1.3 Online Pharmacy
6.2 By Channel, Global Assisted Reproductive Technologies Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Channel, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Assisted Reproductive Technologies Drugs & Forecasts, 2018-2029
7.3.2 By Country, North America Assisted Reproductive Technologies Drugs Market Size Market Share
7.4 Europe
7.4.1 Europe Assisted Reproductive Technologies Drugs Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Assisted Reproductive Technologies Drugs Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Assisted Reproductive Technologies Drugs Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Assisted Reproductive Technologies Drugs Market Size Market Share
7.6 South America
7.6.1 South America Assisted Reproductive Technologies Drugs Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Assisted Reproductive Technologies Drugs Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Assisted Reproductive Technologies Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Assisted Reproductive Technologies Drugs Market Size, 2018-2029
8.3.2 By Type, U.S. Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.3.3 By Channel, U.S. Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Assisted Reproductive Technologies Drugs Market Size, 2018-2029
8.4.2 By Type, Europe Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.4.3 By Channel, Europe Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Assisted Reproductive Technologies Drugs Market Size, 2018-2029
8.5.2 By Type, China Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.5.3 By Channel, China Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Assisted Reproductive Technologies Drugs Market Size, 2018-2029
8.6.2 By Type, Japan Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.6.3 By Channel, Japan Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Assisted Reproductive Technologies Drugs Market Size, 2018-2029
8.7.2 By Type, South Korea Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.7.3 By Channel, South Korea Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Assisted Reproductive Technologies Drugs Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.8.3 By Channel, Southeast Asia Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Assisted Reproductive Technologies Drugs Market Size, 2018-2029
8.9.2 By Type, India Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.9.3 By Channel, India Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Assisted Reproductive Technologies Drugs Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
8.10.3 By Channel, Middle East & Africa Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Merck
9.1.1 Merck Company Information, Head Office, Market Area and Industry Position
9.1.2 Merck Company Profile and Main Business
9.1.3 Merck Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.1.4 Merck Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.1.5 Merck Recent Developments
9.2 MSD
9.2.1 MSD Company Information, Head Office, Market Area and Industry Position
9.2.2 MSD Company Profile and Main Business
9.2.3 MSD Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.2.4 MSD Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.2.5 MSD Recent Developments
9.3 Ipsen
9.3.1 Ipsen Company Information, Head Office, Market Area and Industry Position
9.3.2 Ipsen Company Profile and Main Business
9.3.3 Ipsen Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.3.4 Ipsen Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.3.5 Ipsen Recent Developments
9.4 Ferring
9.4.1 Ferring Company Information, Head Office, Market Area and Industry Position
9.4.2 Ferring Company Profile and Main Business
9.4.3 Ferring Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.4.4 Ferring Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.4.5 Ferring Recent Developments
9.5 Organon
9.5.1 Organon Company Information, Head Office, Market Area and Industry Position
9.5.2 Organon Company Profile and Main Business
9.5.3 Organon Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.5.4 Organon Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.5.5 Organon Recent Developments
9.6 Solvay
9.6.1 Solvay Company Information, Head Office, Market Area and Industry Position
9.6.2 Solvay Company Profile and Main Business
9.6.3 Solvay Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.6.4 Solvay Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.6.5 Solvay Recent Developments
9.7 Besins
9.7.1 Besins Company Information, Head Office, Market Area and Industry Position
9.7.2 Besins Company Profile and Main Business
9.7.3 Besins Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.7.4 Besins Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.7.5 Besins Recent Developments
9.8 Zhejiang Xianju
9.8.1 Zhejiang Xianju Company Information, Head Office, Market Area and Industry Position
9.8.2 Zhejiang Xianju Company Profile and Main Business
9.8.3 Zhejiang Xianju Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.8.4 Zhejiang Xianju Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.8.5 Zhejiang Xianju Recent Developments
9.9 Changchun GeneScience
9.9.1 Changchun GeneScience Company Information, Head Office, Market Area and Industry Position
9.9.2 Changchun GeneScience Company Profile and Main Business
9.9.3 Changchun GeneScience Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.9.4 Changchun GeneScience Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.9.5 Changchun GeneScience Recent Developments
9.10 Hybio Pharmaceutical
9.10.1 Hybio Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.10.2 Hybio Pharmaceutical Company Profile and Main Business
9.10.3 Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.10.4 Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.10.5 Hybio Pharmaceutical Recent Developments
9.11 Livzon Pharmaceutical
9.11.1 Livzon Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.11.2 Livzon Pharmaceutical Company Profile and Main Business
9.11.3 Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Models, Specifications and Application
9.11.4 Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Revenue and Gross Margin, 2018-2023
9.11.5 Livzon Pharmaceutical Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Assisted Reproductive Technologies Drugs Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Assisted Reproductive Technologies Drugs Market Restraints
Table 3. Assisted Reproductive Technologies Drugs Market Trends
Table 4. Assisted Reproductive Technologies Drugs Industry Policy
Table 5. Global Assisted Reproductive Technologies Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Assisted Reproductive Technologies Drugs Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Assisted Reproductive Technologies Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Assisted Reproductive Technologies Drugs Mergers & Acquisitions, Expansion Plans
Table 9. Global Assisted Reproductive Technologies Drugs Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Assisted Reproductive Technologies Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Assisted Reproductive Technologies Drugs Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Assisted Reproductive Technologies Drugs Upstream (Raw Materials)
Table 14. Global Assisted Reproductive Technologies Drugs Typical Customers
Table 15. Assisted Reproductive Technologies Drugs Typical Distributors
Table 16. By Type, Global Assisted Reproductive Technologies Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Channel, Global Assisted Reproductive Technologies Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Assisted Reproductive Technologies Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2018-2029
Table 23. Merck Company Information, Head Office, Market Area and Industry Position
Table 24. Merck Company Profile and Main Business
Table 25. Merck Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 26. Merck Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Merck Recent Developments
Table 28. MSD Company Information, Head Office, Market Area and Industry Position
Table 29. MSD Company Profile and Main Business
Table 30. MSD Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 31. MSD Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. MSD Recent Developments
Table 33. Ipsen Company Information, Head Office, Market Area and Industry Position
Table 34. Ipsen Company Profile and Main Business
Table 35. Ipsen Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 36. Ipsen Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Ipsen Recent Developments
Table 38. Ferring Company Information, Head Office, Market Area and Industry Position
Table 39. Ferring Company Profile and Main Business
Table 40. Ferring Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 41. Ferring Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Ferring Recent Developments
Table 43. Organon Company Information, Head Office, Market Area and Industry Position
Table 44. Organon Company Profile and Main Business
Table 45. Organon Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 46. Organon Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Organon Recent Developments
Table 48. Solvay Company Information, Head Office, Market Area and Industry Position
Table 49. Solvay Company Profile and Main Business
Table 50. Solvay Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 51. Solvay Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Solvay Recent Developments
Table 53. Besins Company Information, Head Office, Market Area and Industry Position
Table 54. Besins Company Profile and Main Business
Table 55. Besins Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 56. Besins Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Besins Recent Developments
Table 58. Zhejiang Xianju Company Information, Head Office, Market Area and Industry Position
Table 59. Zhejiang Xianju Company Profile and Main Business
Table 60. Zhejiang Xianju Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 61. Zhejiang Xianju Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Zhejiang Xianju Recent Developments
Table 63. Changchun GeneScience Company Information, Head Office, Market Area and Industry Position
Table 64. Changchun GeneScience Company Profile and Main Business
Table 65. Changchun GeneScience Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 66. Changchun GeneScience Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Changchun GeneScience Recent Developments
Table 68. Hybio Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 69. Hybio Pharmaceutical Company Profile and Main Business
Table 70. Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 71. Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Hybio Pharmaceutical Recent Developments
Table 73. Livzon Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 74. Livzon Pharmaceutical Company Profile and Main Business
Table 75. Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Models, Specifications, and Application
Table 76. Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Livzon Pharmaceutical Recent Developments
List of Figures
Figure 1. Assisted Reproductive Technologies Drugs Picture
Figure 2. Global Assisted Reproductive Technologies Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Assisted Reproductive Technologies Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Assisted Reproductive Technologies Drugs Market Share of Global, 2018-2029
Figure 5. Global Assisted Reproductive Technologies Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Assisted Reproductive Technologies Drugs Key Participants, Market Share, 2022
Figure 7. Assisted Reproductive Technologies Drugs Industry Chain
Figure 8. Assisted Reproductive Technologies Drugs Procurement Model
Figure 9. Assisted Reproductive Technologies Drugs Sales Model
Figure 10. Assisted Reproductive Technologies Drugs Sales Channels, Direct Sales, and Distribution
Figure 11. Down-Regulation Drugs
Figure 12. Ovulation Stimulation Drugs
Figure 13. Ovulation Inducing Drugs
Figure 14. Luteal Support Medications
Figure 15. By Type, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 16. By Type, Global Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2018-2029
Figure 17. Hospital Pharmacy
Figure 18. Specialty & Retail Pharmacy
Figure 19. Online Pharmacy
Figure 20. By Channel, Global Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 21. By Channel, Global Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2018-2029
Figure 22. By Region, Global Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2018-2029
Figure 23. North America Assisted Reproductive Technologies Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, North America Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022
Figure 25. Europe Assisted Reproductive Technologies Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, Europe Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022
Figure 27. Asia Pacific Assisted Reproductive Technologies Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 28. By Country/Region, Asia Pacific Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022
Figure 29. South America Assisted Reproductive Technologies Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 30. By Country, South America Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022
Figure 31. Middle East & Africa Assisted Reproductive Technologies Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 32. U.S. Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 33. By Type, U.S. Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 34. By Channel, U.S. Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 35. Europe Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 36. By Type, Europe Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 37. By Channel, Europe Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 38. China Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 39. By Type, China Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 40. By Channel, China Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 41. Japan Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 42. By Type, Japan Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 43. By Channel, Japan Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 44. South Korea Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 45. By Type, South Korea Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 46. By Channel, South Korea Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 47. Southeast Asia Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 48. By Type, Southeast Asia Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 49. By Channel, Southeast Asia Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 50. India Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 51. By Type, India Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 52. By Channel, India Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 53. Middle East & Africa Assisted Reproductive Technologies Drugs Consumption Value, 2018-2029, US$ Million
Figure 54. By Type, Middle East & Africa Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 55. By Channel, Middle East & Africa Assisted Reproductive Technologies Drugs Consumption Value Market Share, 2022 VS 2029
Figure 56. Research Methodology
Figure 57. Breakdown of Primary Interviews
Figure 58. Bottom-up and Top-down Approaches
Figure 59. Top-down Approaches
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets